PubRank

J J Mond

Author PubWeight™ 143.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Proc Natl Acad Sci U S A 1991 3.57
2 Persistent calcium elevation correlates with the induction of surface immunoglobulin-mediated B cell DNA synthesis. J Exp Med 1993 2.88
3 Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol Rev 1977 2.50
4 Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med 1992 2.47
5 Towards a comprehensive view of immunoglobulin class switching. Immunol Today 1993 2.44
6 Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function. J Exp Med 1985 2.27
7 Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin. J Immunol 1981 2.26
8 Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers. J Exp Med 1977 2.18
9 B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev 2000 2.17
10 T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus. Eur J Immunol 1978 2.13
11 The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect. J Immunol 1977 2.03
12 Polyclonal activation of the murine immune system by an antibody to IgD. II. Generation of polyclonal antibody production and cells with surface IgG. J Immunol 1982 1.96
13 Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation. J Immunol 1988 1.84
14 Role of T lymphocytes in the response to TNP-AECM-Ficoll. J Immunol 1980 1.66
15 Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells. J Immunol 1986 1.66
16 Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody. J Immunol 1985 1.60
17 Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J Exp Med 1993 1.56
18 A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J Immunol 1996 1.56
19 Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents. Vaccine 1996 1.51
20 Production of BSF-1 during an in vivo, T-dependent immune response. J Immunol 1986 1.47
21 Early development of the T cell repertoire. In vivo treatment of neonatal mice with anti-Ia antibodies interferes with differentiation of I-restricted T cells but not K/D-restricted T cells. J Exp Med 1983 1.35
22 Immune response to levan. III. The capacity to produce anti-inulin antibodies and cross-reactive idiotypes appears late in ontogeny. J Immunol 1979 1.34
23 Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. J Biol Chem 1988 1.33
24 Role of the thymus in directing the development of a subset of B lymphocytes. J Exp Med 1982 1.32
25 Interferon-gamma inhibits the action of B cell stimulatory factor (BSF)-1 on resting B cells. J Immunol 1986 1.32
26 Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence. J Immunol 1991 1.29
27 The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody. J Cell Biol 1988 1.28
28 B cell stimulatory factor 1 (BSF-1) prepares resting B cells to enter S phase in response to anti-IgM and lipopolysaccharide. J Exp Med 1986 1.27
29 In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties. J Immunol 1986 1.27
30 IgE class switching is critically dependent upon the nature of the B cell activator, in addition to the presence of IL-4. J Immunol 1991 1.27
31 T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells. J Immunol 1985 1.26
32 Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation. J Immunol 1992 1.21
33 Role of a nonimmunoglobulin cell surface determinant in the activation of B lymphocytes by thymus-independent antigens. J Exp Med 1979 1.19
34 Surface immunoglobulin crosslinking activates a tyrosine kinase pathway in B cells that is independent of protein kinase C. Proc Natl Acad Sci U S A 1991 1.19
35 "Numatrin," a nuclear matrix protein associated with induction of proliferation in B lymphocytes. J Biol Chem 1987 1.17
36 Polyclonal activation of the murine immune system by an antibody to IgD. I. Increase in cell size and DNA synthesis. J Immunol 1982 1.16
37 Use of the T lymphocyte regulated type 2 antigens for the analysis of responsiveness of Lyb5+ and Lyb5- B lymphocytes to T lymphocyte derived factors. Immunol Rev 1982 1.16
38 T lymphocyte-dependent B lymphocyte proliferative response to antigen. I Genetic restriction of the stimulation of B lymphocyte proliferation. J Exp Med 1981 1.15
39 Distinct types of T-cell help for the induction of a humoral immune response to Streptococcus pneumoniae. Trends Immunol 2001 1.13
40 B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae. J Immunol 2000 1.11
41 Analysis of B cell activation requirements with TNP-conjugated polyacrylamide beads. J Immunol 1979 1.10
42 In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions. J Immunol 1999 1.10
43 The importance of theta and Ig hearing cells in the immune response to various antigens. J Immunol 1971 1.10
44 Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA. J Immunol 1984 1.10
45 Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population. J Immunol 1983 1.08
46 T cell dependence and factor reconstitution of in vitro antibody responses to TNP-B. Abortus and TNP-Ficoll: restoration of depleted responses with chromatographed fractions of a T cell-derived factor. J Immunol 1983 1.07
47 Affinity-purified interleukin 2 induces proliferation of large but not small B cells. Proc Natl Acad Sci U S A 1985 1.06
48 Induction of primary and inhibition of secondary antibody response to hapten by hapten conjugates of type III pneumococcal polysaccharide. Cell Immunol 1975 1.06
49 Heterogeneity of Ia expression on normal B cells, neonatal B cells, and on cells from B cell-defective CBA/N mice. J Immunol 1980 1.06
50 Greater sensitivity to inhibition by anti-immunoglobulin of splenic than of bone marrow B-lymphocytes. J Immunol 1973 1.05
51 Comparative in vitro analysis of proliferation, Ig secretion, and Ig class switching by murine marginal zone and follicular B cells. J Immunol 1993 1.05
52 Thymus-derived cell (T cell) activation by heterologous antigens as a replacement of specific immune T cells in the transfer of the secondary response to sheep erythrocytes. J Exp Med 1972 1.05
53 Kinetics of B cell memory development during a thymus "independent" immune response. Cell Immunol 1974 1.04
54 Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. A redefinition of the TI-2 vs T cell-dependent antigen dichotomy. J Immunol 1995 1.03
55 Surface antigens of immunocompetent cells. IV. Effect of anti-b5 allotype on immunologic responses of homozygous b5 rabbit cells in vitro. J Immunol 1972 1.03
56 An in vitro model for T cell-independent induction of humoral immunity. A requirement for NK cells. J Immunol 1994 1.03
57 Surface immunoglobulin-mediated B-cell activation in the absence of detectable elevations in intracellular ionized calcium: a model for T-cell-independent B-cell activation. Proc Natl Acad Sci U S A 1989 1.02
58 IL-10 selectively regulates murine Ig isotype switching. Int Immunol 1996 1.01
59 Natural killer cells induce activated murine B cells to secrete Ig. J Immunol 1993 0.98
60 Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody. J Immunol 1983 0.98
61 Synergistic genetic defect in B-lymphocyte function. I. Defective responses to B-cell stimulants and their genetic basis. J Exp Med 1980 0.96
62 Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotide motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion. Int Immunol 1999 0.96
63 Bacterial lipoproteins may substitute for cytokines in the humoral immune response to T cell-independent type II antigens. J Immunol 1995 0.94
64 Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells. J Immunol 1987 0.93
65 Corticosteroid induction of Ig+Ia- B cells in vitro is mediated via interaction with the glucocorticoid cytoplasmic receptor. J Immunol 1988 0.93
66 IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. J Immunol 1993 0.93
67 Neonatal suppression with anti-Ia antibody. I. Suppression of murine B lymphocyte development. J Immunol 1982 0.92
68 Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccharides. Vaccine 2000 0.92
69 Different patterns of inositol polyphosphate production are seen in B lymphocytes after cross-linking of sIg by anti-Ig antibody or by a multivalent anti-Ig antibody dextran conjugate. J Immunol 1989 0.92
70 Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2. Infect Immun 1998 0.92
71 Evidence for DNA binding activity of numatrin (B23), a cell cycle-regulated nuclear matrix protein. Biochim Biophys Acta 1990 0.91
72 Biochemical analysis of the immune B cell defect in xid mice. J Immunol 1991 0.91
73 Neisserial porins may provide critical second signals to polysaccharide-activated murine B cells for induction of immunoglobulin secretion. Infect Immun 1997 0.90
74 Prospects for vaccines during pregnancy and in the newborn period. Clin Perinatol 1997 0.90
75 Lymphokine control of type 2 antigen response. IL-10 inhibits IL-5- but not IL-2-induced Ig secretion by T cell-independent antigens. J Immunol 1992 0.89
76 Effects of cholera toxin on human B cells. Cholera toxin induces B cell surface DR expression while it inhibits anti-mu antibody-induced cell proliferation. J Immunol 1990 0.89
77 IL-3 and granulocyte-macrophage colony-stimulating factor strongly induce Ig secretion by sort-purified murine B cell activated through the membrane Ig, but not the CD40, signaling pathway. J Immunol 1995 0.89
78 IFN-gamma is a potent inducer of Ig secretion by sort-purified murine B cells activated through the mIg, but not the CD40, signaling pathway. Int Immunol 1996 0.89
79 Antibody affinity in mice with the CBA/N defect. J Immunol 1980 0.89
80 Anti-Ig-mediated proliferation of human B cells in the absence of protein kinase C. J Immunol 1988 0.88
81 In vivo treatment of neonatal mice with anti-I-A antibodies interferes with the development of the class I, class II, and Mls-reactive proliferating T cell subset. J Immunol 1985 0.88
82 Dextran-conjugated anti-IgD antibodies inhibit T cell-mediated IgE production but augment the synthesis of IgM and IgG. J Immunol 1993 0.87
83 Establishment of an inbred line of mice that express a synergistic immune defect precluding in vitro responses to type 1 and type 2 antigens, B cell mitogens, and a number of T cell-derived helper factors. J Exp Med 1983 0.87
84 A method for size separation of murine spleen cells using counterflow centrifugation. J Immunol Methods 1983 0.87
85 Lyb-5- B cells of CBA/N mice can be induced to synthesize DNA by culture with insolubilized but not soluble anti-Ig. J Immunol 1983 0.86
86 Enhancement by monoclonal anti-Lyb-2 antibody of antigen-specific B lymphocyte expansion stimulated by TNP-Ficoll and T lymphocyte-derived factors. J Immunol 1986 0.85
87 Stimulation of the murine immune system by anti-IgD antibodies: a polyclonal model of B-lymphocyte activation by a thymus dependent antigen. Ann N Y Acad Sci 1982 0.85
88 Characterization of early activation events in cord blood B cells after stimulation with T cell-independent activators. Pediatr Res 1998 0.84
89 Expression of Ia antigen on adult and neonatal B lymphocytes responsive to thymus-independent antigens. J Immunol 1979 0.84
90 cAMP-independent effects of cholera toxin on B cell activation. I. A possible role for cell surface ganglioside GM1 in B cell activation. J Immunol 1990 0.84
91 Surface antigens of immunocompetent cells. 3. In vitro studies of the role of B and T cells in immunological memory. J Exp Med 1972 0.84
92 Augmentation of in vitro humoral immune responses in the mouse by an antibody to IgD. J Exp Med 1980 0.83
93 The Mlsd-defined primary mixed lymphocyte reaction: a composite response to Mlsa and Mlsc determinants. J Immunol 1987 0.83
94 Corticosteroid-induced suppression of murine B cell immune response antigens. J Immunol 1986 0.83
95 Polyclonal activation of the murine immune system by an antibody to IgD. X. Evidence that the precursors of IgG1-secreting cells are newly generated membrane IgD+B cells rather than the B cells that are initially activated by anti-IgD antibody. J Immunol 1990 0.83
96 Glucocorticoids suppress calcium mobilization and phospholipid hydrolysis in anti-Ig antibody-stimulated B cells. J Immunol 1987 0.83
97 Immunological memory function of the T and B cell types: distribution over mouse spleen and lymph nodes. Eur J Immunol 1975 0.82
98 B-cell function in mice treated with anti-IgD from birth. Ann N Y Acad Sci 1982 0.82
99 Heterogeneity in the ability of cytotoxic murine NK cell clones to enhance Ig secretion in vitro. Int Immunol 1999 0.80
100 B lymphocyte immunoglobulin receptor desensitization is downstream of tyrosine kinase activation. Cell Immunol 1994 0.80
101 Restoration of T cell-independent type 2 induction of Ig secretion by neonatal B cells in vitro. J Immunol 1997 0.80
102 In vivo administration of anti-I-A antibody induces the internalization of B cell surface I-A and I-E without affecting the expression of surface immunoglobulin. J Immunol 1984 0.80
103 Modulation of B-lymphocyte and NK cell activities by glycoinositolphospholipid purified from Trypanosoma cruzi. Infect Immun 1999 0.79
104 In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes. J Immunol 1986 0.79
105 Analysis of the B cell subpopulations influenced by allogeneic effect factor. I. MHC restricted enhancement of b cell responses to thymic-independent antigens, types 1 and 2, in normal and CBA/N mice. J Immunol 1983 0.78
106 Cholera toxin promotes the proliferation of anti-mu antibody-prestimulated human B cells. Cell Immunol 1992 0.78
107 Effects of neonatal anti-delta antibody treatment on the murine immune system. II. Functional capacity of a stable sIgM+sIa+sIgD- B cell population. J Immunol 1983 0.78
108 T(h)1 versus T(h)2 cytokine profile determines the modulation of in vitro T cell-independent type 2 responses by IL-4. Int Immunol 2000 0.78
109 The distribution of surface IgD on B-lymphocytes of mice: two parameter correlation with surface IgM and Ia. Ann N Y Acad Sci 1982 0.78
110 Synergistic effects of the xid gene in X chromosome congenic mice. I. Inability of C3.CBA/N mice to respond to thymus-dependent antigens in adoptive transfer assays. J Immunol 1987 0.78
111 cAMP-independent effects of cholera toxin on B cell activation. III. Cholera toxin A subunit-mediated ADP-ribosylation acts synergistically with ionomycin or IL-4 to induce B cell proliferation. J Immunol 1995 0.78
112 Enhanced immunogenicity of protein-dextran conjugates: I. Rapid stimulation of enhanced antibody responses to poorly immunogenic molecules. Vaccine 1994 0.78
113 Phenotypic and functional characterization of a panel of cytotoxic murine NK cell clones that are heterogeneous in their enhancement of Ig secretion in vitro. Int Immunol 1998 0.78
114 Proliferative response of normal rabbit and mouse bone marrow cells in vitro. Cell Immunol 1972 0.78
115 Activation of human B lymphocytes by nanogram concentrations of anti-IgM-dextran conjugates. Eur J Immunol 1990 0.78
116 Genetic analysis of the presentation of minor lymphocyte-stimulating determinants. II. Differing non-MHC control of super-stimulatory and more poorly stimulatory Mls phenotypes. J Immunol 1990 0.78
117 B-cell activation stimulated by monoclonal anti-Lyb2.1 antibody is mediated through a receptor distinct from the BSF-1 receptor. Cell Immunol 1987 0.78
118 Comparison of the calcium requirement for the induction and maintenance of B cell class II molecule expression and for B cell proliferation stimulated by mitogens and purified growth factors. J Immunol 1987 0.77
119 8-Hydroxyguanosine and 8-methoxyguanosine possess immunostimulating activity for B lymphocytes. Cell Immunol 1985 0.77
120 Cross-linkage of Ly-6A/E induces Ca2+ translocation in the absence of phosphatidylinositol turnover and mediates proliferation of normal murine B lymphocytes. J Immunol 1991 0.77
121 Enhanced and sustained activation of human B cells by anti-immunoglobulin conjugated to the EBV glycoprotein gp350. Eur J Immunol 2000 0.77
122 Comparison of tyrosine kinase activation by mitogenic and nonmitogenic anti-IgD antibodies. J Immunol 1992 0.77
123 Heterogeneity of complement receptor expression on surface immunoglobulin-bearing cells from neonatal and adult mice. Eur J Immunol 1982 0.77
124 Restoration of in vitro responsiveness of xid B cells to TNP-Ficoll by 8-mercaptoguanosine. J Immunol 1986 0.77
125 Effects of anti-immunoglobulin antibodies on murine B lymphocytes and humoral immune responses. Immunol Rev 1980 0.77
126 Examination of the inhibitory and stimulatory effects of IFN-alpha, -beta, and -gamma on human B-cell proliferation induced by various B-cell mitogens. Clin Immunol Immunopathol 1988 0.76
127 Treatment with dextran-conjugated anti-IgD delays the development of autoimmunity in MRL-lpr/lpr mice. J Immunol 1994 0.76
128 B lymphocyte immune response gene phenotype is genetically determined. J Exp Med 1982 0.75
129 Superstimulatory influenza virus and highly organized BCR-ligands act synergistically on B cell activation. Immunobiology 1996 0.75
130 The effect of linomide, an immunoregulator in experimental autoimmune diseases, on humoral antibody responses in mice. Autoimmunity 1997 0.75
131 Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice. J Immunol 1983 0.75
132 Neonatal suppression with anti-Ia antibody. III. In vivo responses to the type 2 antigen TNP-Ficoll. J Immunol 1989 0.75
133 High anti-TNP plaque-forming cell potential of residual mIg+ cells in a T cell population. J Immunol 1980 0.75
134 Polyclonal activation of the murine immune system by an antibody to IgD. III. Ontogeny. Eur J Immunol 1983 0.75
135 Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes. J Immunol 1987 0.75
136 Metabolism of guanosine and its C-8 substituted analogues in human lymphocyte cytoplasm. Adv Exp Med Biol 1989 0.75
137 Immuno affinity purified interleukin 2 (IL2) induces B cell growth. Curr Top Microbiol Immunol 1984 0.75
138 Genetic analysis of the presentation of minor lymphocyte stimulating determinants. I. Combined importance of MHC and non-MHC influences. J Immunol 1988 0.75
139 Control of B cell differentiation by T cells. Surv Immunol Res 1983 0.75
140 Allostimulatory analysis of a newly-defined and widely-distributed Mls superantigen. Immunogenetics 1991 0.75
141 B lymphocyte development, heterogeneity, and function. Arthritis Rheum 1978 0.75
142 T lymphocyte-dependent B lymphocyte proliferative response to antigen. II. Induction of polyclonal B lymphocyte activation of normal B cells and of Lyb-5- B cells from xid mice via recognition of self-IA antigens. J Immunol 1984 0.75
143 Identification of a prominent 85-kDa cAMP-dependent phosphoprotein associated with late G1 phase in mitogen-stimulated B lymphocytes. J Biol Chem 1991 0.75
144 Anti-IgD induced increase in sIa is associated with an increase in B-cell receptivity to help and/or increase in its antigen presenting activity. Ann N Y Acad Sci 1982 0.75
145 IL4 is not required for proliferative responses in B cells stimulated by anti-IgD-dextran conjugates even under limiting conditions of cell-cell interaction. Cell Immunol 1990 0.75
146 PKC activity and protein phosphorylation in regulation of sIg mediated B cell activation. Scand J Immunol 1995 0.75
147 Augmented in vitro presentation of Mls determinants after anti-immunoglobulin-induced B cell activation: ontogeny and role of purified B cells. J Immunogenet 1989 0.75
148 Plasma membrane 5'-nucleotidase and other purine enzymes in murine lymphocytes. Adv Exp Med Biol 1984 0.75
149 Hemolytic anemia with serum and erythrocyte-bound low-molecular-weight IgM. Clin Immunol Immunopathol 1975 0.75